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Solution NMRABC transporters are fascinating examples of ﬁne-tuned molecular machines that use the energy from ATP hydro-
lysis to translocate a multitude of substrates across biological membranes. While structural details have emerged
onmany members of this large protein superfamily, a number of functional details are still under debate. High res-
olution structures yield valuable insights into protein function, but it is the combination of structural, functional and
dynamic insights that facilitates a complete understanding of theworkings of their complexmolecularmechanisms.
NMR is a technique well-suited to investigate proteins in atomic resolution while taking their dynamic properties
into account. It thus nicely complements other structural techniques, such as X-ray crystallography, that have con-
tributed high-resolution data to the architectural understanding of ABC transporters. Here, we describe the heterol-
ogous expression of LmrA, an ABC exporter from Lactococcus lactis, in Escherichia coli. This allows for more ﬂexible
isotope labeling for nuclear magnetic resonance (NMR) studies and the easy study of LmrA's multidrug resistance
phenotype. We use a combination of solid-state magic angle spinning (MAS) on the reconstituted transporter and
solution NMR on its isolated nucleotide binding domain to investigate consequences of nucleotide binding to
LmrA.Weﬁnd that nucleotide binding affects the protein globally, but thatNMR is also able to pinpoint local dynam-
ic effects to speciﬁc residues, such as the Walker A motif's conserved lysine residue.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
ATP Binding Cassette (ABC) transporters are involved in the transport
of a multitude of different compounds including ions, nutrients, antibi-
otics and even peptides and lipids across cellular membranes [1]. ABCadenosine diphosphate; ATP,
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mich),
ted, 7300 Cambridge Researchtransporters recognize and translocate their substrates through a helical
transmembrane domain (TMD). Their name stems from the use of ATP
as their energy source to facilitate substrate transport. ATP is hydrolyzed
in the so-called nucleotide binding domains (NBDs). The general archi-
tecture of ABC transporters features a structural dimer of two transmem-
brane regions and two nucleotide binding domains. An intriguing subset
of ABC transporters does notmove a single, deﬁned substrate or substrate
class across membranes but rather a large number of chemically unrelat-
ed compounds. These are the multidrug resistance (MDR) ABC trans-
porters [2]. They play important roles in bacterial antibiotic resistance
and resistance to chemotherapeutics in cancer treatment. LmrA, a bacte-
rial homodimeric multidrug ABC transporter from Lactococcus lactis ho-
mologous to human P-glycoprotein is one such example [3].
The general features of substrate transport and ATP hydrolysis by
ABC transporters have been elucidated by a vast number of structural
and functional studies, but even so, a number of key concepts remain
unclear. Especially in the realm of MDR transporters, details of how
these proteins select and recognize their diverse substrates remain
amiss. The coupling of ATP hydrolysis and substrate transport which
goes hand in hand with large global conformational changes in the
transmembrane domain is also not fully understood. Intriguingly, a
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be highly ﬂexible, at least at certain intermediate points throughout
their ATP hydrolysis and substrate translocation cycle [4–6]. Intrinsic
ﬂexibility is a feature they share with other multidrug translocators,
such as members of the small multidrug resistance (SMR) protein fam-
ily or the Resistance Nodulation cell Division (RND) superfamily [7–9].
For LmrA, it was shown previously by electron paramagnetic reso-
nance (EPR) spectroscopy that there are vast changes in global dynam-
ics between nucleotide-free and nucleotide-bound states [10]. Similar
effects were observed for other ABC transporters e.g. [11]. It may be
speculated that in addition to the overall global effects observed upon
nucleotide binding, local dynamicswill change aswell. ABC transporters
contain a number of highly conserved sequencemotifs that are essential
for domain communication and ATP hydrolysis [12,13]. We hypothe-
sized that changes in protein dynamics should be especially apparent
in these regions as they govern and collate information from substrate
and nucleotide binding to ﬁne-tune the concerted large range motions
required for an ABC transporter to efﬁciently fulﬁll its task of moving
substrates across the membrane.
In particular, catalytic residues within the NBD should probably be
strongly affected. Membership in the ABC superfamily is contingent on
the presence of the signature motif, the “C-loop”. Other conserved re-
gions within the NBD essential for ATP hydrolysis are the Walker A
and Walker B motif. The Walker A motif has the consensus sequence
G/AxxxxGKT/S (with x = any amino acid) [14]. The side-chain of the
conserved lysine residue (K388 in LmrA) interacts with the γ-
phosphate of ATP during the hydrolysis reaction. Its mutagenesis can
lead to signiﬁcantly decreased ATPase activity and/or disrupts nucleo-
tide binding [15–18].
When an ABC transporter undergoes its substrate translocation/ATP
hydrolysis cycle, ATP binding and/or hydrolysis at the NBDs is coupled
to conformational changes within the transmembrane region. Both
the substrate and the ATP hydrolysis products (free phosphate and
ADP) are released and the transporter is reset for a new cycle. To stably
“trap” intermediates of the ABC transporter cycle for spectroscopic in-
vestigations, pre-hydrolysis or transition state analogues are commonly
used. Trapping is achieved after a single round of ATP turnover. The
resulting ADP is trapped by the exchange of Pi to a metal phosphate an-
alogue (e.g. beryllium ﬂuoride (BeFx) or vanadate (Vi)) with a signiﬁ-
cantly higher afﬁnity to the phosphate binding site. While beryllium
ﬂuoride mimicks the tetrahedral geometry of the pre-hydrolysis state,
vanadate emulates the pentavalent bipyramidal architecture of the
transition state. InABC transporters, trappingwithphosphate analogues
was successfully demonstrated on numerous systems [19–21].
The tremendous improvements in crystallization-based structure
determinations of secondary and primary active transporters create a
need and offer the possibility for extensive spectroscopic studies to
link structure and dynamic data with functional mechanisms. NMR is
especially well suited since site-resolved data can be obtained for vari-
ous catalytic states of proteins. In case of membrane proteins, solid-
state NMR, in particular based on magic angle sample spinning, is the
method of choice due to the possibility to work in the lipid bilayer
[22–24].
Indeed, LmrAwas the ﬁrst ABC transporter for which the application
of solid-state NMR has been attempted. These early trials focused ﬁrst
on establishing isotope labeling in L. lactis [25], on the application of
wide-line 2H NMR to probe the overall dynamics of LmrA [26] and on
assessing the activity of reconstituted LmrA by 31P-MAS NMR [17]. Un-
fortunately, the limitations of the L. lactis expression system with re-
spect to isotope labeling had limited further studies at that time.
It has been demonstrated in the meantime that promising MAS-
NMR spectra can be obtained from ABC transporters expressed in
Escherichia coli. Examples involve the thermophilic import system
ArtMP [27], the Bacillus subtilus ABC exporter BmrA [28] as well as
E. coli MsbA, which was probed in its apo-state as well as in complex
with lipid A [29].Here, we now report also for LmrA the heterologous expression in
E. coliminimal and deﬁned medium for isotope labeling for NMR stud-
ies. Our data show that LmrA from E. coli shows the same functional fea-
tures as L. lactis LmrA which make testing of the integrity our NMR
constructs very convenient and straight-forward. In L. lactis however,
LmrCD has also been described as an important in vivo ABC MDR
pump [30]. Sufﬁcient amounts of isotope-labeled LmrA for NMR spec-
troscopy can be obtained. For solid-state MAS-NMR studies, the trans-
porter was reconstituted into lipid bilayers. Its global dynamics was
empirically assessed by temperature-dependent MAS-NMR detection
through INEPT, cross-polarization and direct polarization experiments.
Residue selective nitrogen labeling was used to probe the effect of nu-
cleotide binding onto the spectral lineshapes of lysine and tryptophan
residues. In addition, isolated isotope-labeled NBDs were prepared
and the inﬂuence of nucleotide binding was probed by solution-state
NMR.
2. Material and methods
All chemicalswere purchased fromApplichem (Darmstadt, Germany)
unless indicated otherwise. Lipids were purchased from Avanti Polar
Lipids (Alabaster, AL, USA).
2.1. Cloning of the lmrA gene
The lmrA gene was excised from the lactococcal plasmid pNHLmrA as
a NcoI-SacI fragment and subcloned into the E. coli vector pET28b(+)
(Novagen). The resulting plasmids were transformed into E. coli strain
BW25113ΔAcrB (a gift from K.M. Pos, Frankfurt) for functional character-
ization or T7 Express cells (NEB) for labeling and expression for NMR ex-
periments. As controls, empty pET28b or pET24acrB plasmids were used.
2.2. Protein expression and puriﬁcation
For full-length LmrA expression, E. coli cells were grown at 37 °C in
LB medium (Roth) with 25 μg/mL kanamycin sulfate at 205 rpm in an
orbital shaker to an OD660 of 0.8. They were then induced with 1 mM
IPTG (Roth) and grown for another 2 h. LmrA–NBD was expressed and
puriﬁed as previously described [31]. For isotope labeling deﬁnedmedi-
um supplemented with 15N-lysine or 15N-tryptophan (Eurisotope) was
used. His-tagged full-length LmrA was puriﬁed from ISOVs and trapped
as described [10]. Pure protein yieldswere determinedwith the DC Pro-
tein Assay (BioRad) and veriﬁed with SDS-PAGE. Total membrane pro-
tein and protein yield after puriﬁcation were determined with the
colourimetric DC Protein Assay (BioRad) and photometrically detected
(Jasco V-550 UV/VIS Spectrophotometer).
2.3. Vesicle preparation
Inside–out vesicles were prepared by dissolving cells in 5 mL lysis
buffer (250 mM sucrose, 150 mM NaCl, 10 mM Tris-Cl, pH 7.5, 2.5 mM
MgSO4, 25 μg/mL DNaseI and protease inhibitors) per gram of wet
weight cells. Vesicles were formed by three passes through a cell
disruptor (Constant Systems) at 1.7 kbar. 15 mM K-EDTA, pH 8 was
added to the lysate and cell debris removed by centrifugation. ISOV
were then collected by ultracentrifugation and homogenized in
50mMKPi buffer, pH 7, 10% glycerol. RSOVwere prepared as previously
described [32]. In short, cells were harvested in mid-exponential phase
and lysed with 20 μg/mL lysozyme. Spheroplasts were harvested by
centrifugation and then diluted 300-fold. Whole cells and spheroplasts
were separated frommembrane vesicles in a subsequent centrifugation
step (60 min, 10,000 g). The pellet was homogenized and the suspen-
sion centrifuged. The supernatant was collected and centrifuged
(30 min, 50,000 g) to harvest right side out vesicles. RSOV were
aliquoted and stored in liquid nitrogen until use.
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BW25113ΔAcrB cells containing plasmids pET28b, pET28blmrA or
pET24acrBwere grown and induced as described above. Cells were har-
vested by centrifugation,washed three times in 50mMKPi buffer, pH 7,
and incubated for 10 min at 30 °C with 1 mM NaEDTA, pH 7. Then
10 mM MgSO4 was added, cells were resuspended to an OD660 of 5,
stored on ice and used within 2 h at an OD660 of 0.5. 30 s after dilution,
ethidium bromide or Hoechst 33342 was added to a ﬁnal concentration
of 20 μMor 25 μM respectively and drug uptakewasmonitored by ﬂuo-
rescence (excitation/emission wavelengths were 500/580 nm for
ethidium bromide and 355/457 nm for Hoechst 33342). Vesicle trans-
port assayswere performed as described for lactococcalmembrane ves-
icles [33]. ATPase levels of puriﬁed protein were determined with and
without ethidium bromide and Hoechst 33342 using a linked NADH-
dependent ATPase assay as described previously [34]. ATPase activity
errors are given as standard deviation.
2.5. Reconstitution
POPC and POPG (70:30 (w/w))weremixed in chloroform, dried and
resuspendend in buffer. For liposomes, a 4 mg/mL solution of lipids was
prepared in 50 mM Hepes, pH 7 and extruded (Northern Lipid Extrud-
er). Liposomes were destabilized by titration with 10% TritonX-100.
Destabilized liposomes were combined with eluted protein in a ratio
of 150:1 (mol/mol) and detergent was extracted with Biobeads
(BioRad).
2.6. Freeze fracture electron microscopy
Freeze fracture replicas produced in the freeze-fracture unit BAF 060
(Bal-TEC Inc., Principality of Liechtenstein)were analyzed in an EM208S
electron microscope (FEI Company).
2.7. MAS NMR
13C and 15N MAS NMR cross-polarization experiments were per-
formed on a BrukerAvance 600 MHz spectrometer equipped with a
4 mmDVT HXY triple resonance probe head. Experiments were carried
outwithmagic angle spinning of 10 kHz at 245 K. A typical 1H 90° pulse
was 3 μs (6 dB). A typical Hartmann–Hahn contact time for 13C cross-
polarization was 3 ms (8 dB) carried out with a 80–100% ramp and
1ms (5 dB) for 15N. Recycle delay times were 2 s. For 15N lysine spectra,
37 k scans were recorded, for 15N-Trp 111 k and 76 k scans for the apo
and trapped states respectively. Line broadening was 5 Hz. During ac-
quisition, protons were typically decoupled with 90 kHz decoupling
bandwidth. 13C spectra were referenced to TMS at 0 ppm and 15N spec-
tra to ammonium sulfate at 27 ppm. Data were processed with TopSpin
2.0 (Bruker). A homologymodel for LmrA was built using ClustalW and
Swiss model based on the X-ray structure of the Staphylococcus aureus
homologue Sav1866 [2ONJ] [35].
2.8. Solution NMR
Experiments were carried out on a BrukerAvance 600 MHz spec-
trometer with a cryogenic probe. Samples in 50 mM BisTris pH 6.5,
100 mM NaCl were concentrated to approx. 400 μM and 10% D2O for
lock purposes was added. Temperature was kept at 298 K during titra-
tion. TROSY-based 15N-HSQC spectra were recorded using a standard
pulse sequence with 16 scans and 128 complex points in the f1-
dimension. Assignments were derived from the previously published
assignment of the ADP-bound LmrA–NBD [31]. For stability reasons, ti-
trations shown here were also carried out with ADP. Apo state assign-
ments were deduced based on the ﬁnal peak position after titration.
Data were processed with TopSpin 2.0 (Bruker).3. Results
3.1. Heterologously expressed LmrA is functional
To obtain the large amounts of protein necessary to carry out NMR
spectroscopy, we established the expression and puriﬁcation of LmrA
from E. coli. An amount of 2–4 mg of pure LmrA per liter of culture
could be obtained (Fig. 1F). E. coli is a well-established host for isotope
labeling and high-yield production of proteins. In contrast, no such ef-
fective isotope labelingmedia exist for L. lactis, LmrA's native host. To as-
certain that heterologously expressed LmrA still shows the same
functional characteristics compared to its natively expressed counter-
part in L. lactis, functional assays were carried out in E. coli cells, in
inside-out and right-side out vesicles as well as on puriﬁed protein
(Fig. 1, Fig. S1). For cell-based assays, an AcrB deﬁcient E. coli strain
was used [36]. AcrB is the inner membrane component of the AcrAB-
TolC major multidrug efﬂux system in this bacterium. All three compo-
nents are necessary to conduct efﬁcient multidrug efﬂux [37]. Using
these cells, measurement of LmrA activity, without the strong back-
ground that the tripartite systemAcrAB-TolCwould procure, is possible.
We observed strong extrusion of ﬂuorescent drugs (Hoechst 33342 and
ethidium bromide) in the presence of plasmid encoded LmrA or when
AcrB was re-introduced into cells. When cells were transformed with
an empty vector, no drug efﬂux was observed (Fig. 1A, B). To test for
ATP-dependence of drug extrusion, so-called inside-outmembrane ves-
icles (ISOVs) were prepared. Because the NBD is exposed to the outside
of the membrane vesicles, Hoechst 33342 ﬂuorescence can be detected
after addition of ADP or ATP. Hoechst 33342 ﬂuoresces strongly in the
lipid environment but much less so in an aqueous environment. The
assay shows that Hoechst 33342 is transported from the phospholipid
bilayer after addition of ATP (Fig. 1D). Conveniently, expression of
LmrA in E. coli can also be used to demonstrate drug transport in depen-
dence of ΔpH by taking advantage of respiratory enzymes in E. coli to
build up a proton motif force [38] (Fig. S1). Thus, in both cell andmem-
brane vesicle based assays, LmrAproduced in E. coli can efﬁciently trans-
locate drugs in dependence of ATP or pmf. In return, these drugs are able
to stimulate ATP hydrolysis (Fig. 1C), while beryllium ﬂuoride and van-
adate in their capacity as stable pre-hydrolysis and transition state ana-
logs inhibit ATP hydrolysis (Fig. 1G). The homogeneity of the
heterologously produced protein after reconstitution and the absence
of aggregates were veriﬁed by freeze-fracture electron microscopy
(Fig. 1E).
3.2. MAS-NMR on reconstituted LmrA
Using uniformly 13C-labeled LmrA, we probedwhether we can distin-
guish global rigid (as measured by 13C cross-polarization (CP) NMR) and
global ﬂexible regions (as measured by 13C inept (insensitive nuclei en-
hanced by polarization transfer) NMR) of our sample (Figs. S2, S3). In-
deed, both rigid and more dynamic regions were observable and as
expected, overall dynamic behavior signiﬁcantly increases while rigid re-
gions decrease as the temperature is raised. At each temperature, the lipid
phase was probed by 1H MAS-NMR. The presence of LmrA reduces the
lipid main phase transition temperature (Fig. S3). Unfortunately, we ob-
served large peak overlap and broad resonances in the two-dimensional
13C–13C proton driven spin diffusion (PDSD) spectra of U13C-LmrA,
which were performed to detect cross-peaks for carbon resonances
close in space (not shown). This prevented us from carrying outmore de-
tailed analyses with these samples. As an alternative approach, amino
acid speciﬁc labeling was carried out instead (Figs. 2, 3).
3.3. MAS-NMR on 15N-lysine and 15N-tryptophan labeled LmrA
Lysine and tryptophan residues were chosen for amino-acid speciﬁc
15N-isotope labeling. These amino acids are not scrambled in E. coli and
are thus labeled efﬁciently and selectively. Both lysine and tryptophan
Fig. 1. Heterologously expressed LmrA is fully functional. (A, B) LmrA protects cells against ﬂuorescent drugs such as ethidium bromide and Hoechst 33342 as shown by drug extrusion
assays carried out in anE. coliΔAcrBdeletion strain. (C)Drugs stimulate the LmrAATPase. (D)Drug extrusion isATP dependent as demonstrated byHoechst 33342 efﬂux from E. coli ISOVs
(see also Fig. S1 for demonstration of drug transport by pmf). (E) Freeze fracture cryo electron microscopy (16 k magniﬁcation) of reconstituted LmrA in synthetic lipid liposomes shows
homogenous incorporation into liposomes. (F) LmrA can be puriﬁed from E. coli. (G) The ATPase activity of LmrA is inhibited by pre-hydrolysis and transition state nucleotide analogs.
Fig. 2.Nucleotide trapping changes local dynamics of 15N-Lys LmrA. (A) 15N CPMAS NMR on U15N-Lys labeled LmrA shows well separated backbone and sidechain resonances. There are
clear differences between the apo state (black) and the trapped state (red). Upon trapping, the spectrum shows enhanced ﬁne structure in the backbone region in agreement with amore
structurally deﬁned state of LmrA. Also, there is now an additional 15Nζ resonance (yellow circle)whose intensity corresponds to 1/25th of the total sidechain resonance integral and could
thus potentially correspond to a single lysine out of the 29 in LmrA. This 15Nζ resonance was therefore be tentatively assigned to be the conserved lysine residue (K388) of theWalker A
motif. Inset: Homology model of LmrA on Sav1866 (pdb: 2ONJ) [35] with lysine residues shown as yellow sticks.
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Fig. 3.MAS NMR on reconstituted 15N-Trp labeled LmrA. (A) 15N CP MAS NMR on U15N-
Trp labeled LmrA shows well separated backbone and sidechain resonances. From the
apo state (black) to the trapped state (red) more ﬁne structure in backbone and sidechain
peaks is visible. Inset: Homology model of LmrA on Sav1866 (pdb: 2ONJ) [35] with tryp-
tophan residues shown as orange sticks.
Fig. 4.Nucleotide binding changes local dynamics of LmrAK388. (A) SolutionNMR 1H-15N
HSQC of selectively labeled 15N-Lys LmrA NBD in the absence (black) and presence of nu-
cleotide (red). Assignments for all lysine residues have been obtained from U-2H13C15N-
labeled LmrA-NBD [31]. In the apo state (black) all lysine residues except the conserved
Walker A K388 can be observed. Addition of nucleotide leads to the appearance of the
backbone resonance for K388 while only minimally affecting all other lysine residues
thus indicating a strong dynamic stabilization of this speciﬁc residue upon nucleotide
binding. (B) Homology model of LmrA on Sav1866 [35] showing the position of K388
(yellow stick).
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NBDs (Figs. 2, 3). They also contain nitrogen atoms in their backbone as
well as their sidechain. These nitrogen NMR signals tend to bewell sep-
arated within 15N spectra [39], (http://www.bmrb.wisc.edu/ref_info/
statsel.htm). MAS NMR experiments with U15N-Lys or U15N-Trp LmrA
will thus yield information on both the backbone and sidechain of select
amino acids. LmrA contains only ﬁve tryptophan residues, two in the
NBD and three in the TMD (Fig. 3). Because tryptophan is the least com-
mon amino acid type in LmrA, we hoped for enhanced resolution with
this residue. Lysine was labeled, because there is a highly conserved ly-
sine (K388 in LmrA) in theWalker Amotif of ABC transporters that is in-
volved in ATP hydrolysis. The sidechain of the Walker A residue K388
comes into close proximity with the gamma phosphate of ATP that is
exchanged for a pre-hydrolysis or transition state analog during
“nucleotide trapping”. In order to obtain a homogenous protein prepa-
ration in the presence of nucleotides, we tested the ability of vanadate
and beryllium ﬂuoride to inhibit the ATPase activity of LmrA (Fig. 1G).
LmrA could be labeled with both U15N-Lys and U15N-Trp in E. coli and
the 15NMASNMR spectra of the reconstituted protein show the expected
separation between backbone and side-chain resonances (Figs. 2, 3). In
both cases, backbone resonances are broad in the absence of nucleotides
and no individual peaks are discernible. Upon trapping, the backbone res-
onances become narrower (well visible in tryptophan backbone, Fig. 3)
and showmore ﬁne structure (well visible in lysine backbone, Fig. 2).
The most profound change upon nucleotide trapping was observed
in the sidechain region of U15N-lysine LmrA (Fig. 2). The long sidechain
capped by the Nζ amide group is usually highly ﬂexible and lysine resi-
dues are typically found on the protein surface (thus in a similar chem-
ical environment). In agreement with this, all lysine sidechains of LmrA
show a single resonance at the same chemical shift in the absence of nu-
cleotides at 31.5 ppm. Upon trapping, a second, much smaller 15Nζ side-
chain resonance is observed upﬁeld at 29.5 ppm.3.4. Solution NMR on isolated LmrA-NBD shows residue speciﬁc effects of
nucleotide binding
Carrying out NMR assignments (the correlation of a peak observed
in an NMR spectrum to an individual amino acid) is not trivial for a pro-
tein of the size of LmrA (590 amino acids, homodimeric) and made
more challenging by its inherent ﬂexibility [10] that leads to NMR
peak broadening and thus loss of spectral resolution. These effects also
prevented us to use our uniformly 13C-labeled samples to identify spe-
ciﬁc residues and to analyze them further. To delineate the contribu-
tions of the NBD to the 15N-lysine and 15N-tryptophan chemical shift
changes induced by nucleotide binding in the MAS NMR spectra, we
therefore decided to use solution NMR on selectively labeled LmrA-
NBD (D330-Q590). Here, an assignment of the majority of residues
within the NBD is available [31] which allows pinpointing observed ef-
fects to identiﬁable residues (Figs. 4, 5, S4).
In the 15N-lysine labeled LmrA–NBD spectrum in the absence of nu-
cleotides backbone resonances for eight out of nine lysine residues
within the NBD are clearly observed (Fig. 4). Only K388, the Walker A
motif's conserved lysine, cannot be detected. This resonance appears
only after addition of nucleotide. All other lysine residues remainmostly
unaffected. Sidechain amino group resonances for lysine cannot be ob-
served in a 1H–15N-HSQC spectrum because of the fast exchange of pro-
tons with the aqueous solution. In tryptophan residues however, the
hydrogen atom bound to the indole nitrogen does not usually undergo
exchange and thus both sidechain and backbone 1H–15N resonances
can bemonitored (Fig. 5). NeitherW421norW457 are part of the active
nucleotide binding and hydrolysis site of LmrA. However, both
sidechain and backbone resonances of W421 shift upon nucleotide ad-
dition, while W457 remains unaffected (Fig. 5, S4).
Using solid-state NMR, we could show that heterologously
expressed, reconstituted LmrA is globally affected by nucleotide bind-
ing. Applying solution NMR to the NBD, we could further characterize
local effects of nucleotide binding to a catalytically relevant residue
within the Walker A motif.
4. Discussion
LmrA is a representative of the ABC exporters and shares many
structural and functional properties withmedically importantmembers
of this protein subfamily. Unlike some of its relatives however, it can be
produced and puriﬁed in large amounts from E. coli. Heterologously
expressed and puriﬁed LmrA from E. coli shows the expected behavior
for stimulation of drugs and substrate translocation (Fig. 1, S1). LmrA
Fig. 5. 15N-Trp solutionNMR. Both backbone and sidechain resonances ofW421andW457
in the NBD can be distinguished. Of these, only the resonances forW421 shift upon nucle-
otide addition. (B) Homologymodel of LmrA on Sav1866 [35] showing the position of the
two tryptophan residues within the NBD (orange sticks).
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or pmf-dependent manner in good agreement with previous studies,
e.g. [38]. In return, drugs are able to stimulate the ATPase activity of
LmrA produced in E. coli. These results led us to conclude that heterolo-
gously produced LmrA is a suitable candidate for further spectroscopic
studies.
Uniformly as well as selectively isotope labeled LmrA can be pro-
duced in large amounts in E. coli and successfully reconstituted for
MAS NMR studies.
An important factor inﬂuencing NMR spectra is protein dynamics. Ev-
idence for large helix ﬂuctuations in the apo state of ABC transporters has
been also obtained by EPR experiments, which did showmotional ampli-
tudes of up to 2 nm [10,40]. Thesemotions can take place over a range of
time scales (μsec-msec) and could explain the line-broadening observed
in the backbone resonances of U15N-Trp- and Lys-labeled apo-state LmrA
(Figs. 2, 3).
MAS NMR studies were carried out in a non-frozen regime in the
lipid liquid crystalline phase (Fig. S3). Comparing 1H and 13C-INEPT
MAS NMR spectra of empty liposomes and proteoliposomes, we ob-
served that LmrA inﬂuences the lipid transition temperature. The phys-
iological relevance of this ﬁnding remains unclear but it was shown for
P-glycoprotein that its function is highly sensitive to lipid composition
and bilayer ﬂuidity [41] and that it senses the lateral membrane pres-
sure [42]. The comparison of 13C-CP and -INEPT spectra for LmrA
shows that it is overall quite ﬂexible at ambient temperatures
(Figs. S2, S3). Signals visible in CP experiments mainly arise from
more rigid protein regions— possibly the transmembrane helices. A re-
duction in CP intensity therefore means an enhanced mobility of those
protein segments. In contrast, protein signals in INEPT spectra increase
with temperature (Fig. S3). These signals presumably belong to protein
region undergoing fast, large amplitude motions, such as loops or the
NBDs. These observations are in agreement with those reported for
MsbA [40]. Previous reports on LmrA and BmrA using either 2H-solid
state NMRorH/D exchangemass spectrometry showed large amplitude
motions of ABC exporter NBDs and overall conformational ﬂexibility
[26,11]. Our observation can thus be interpreted by a signiﬁcant mobil-
ity of LmrA in the lipid bilayer ﬂuid phase. Conformational ﬂexibility
may help to accommodate substrates of various sizes and chemical
properties as discussed for otherMDR proteins [43,44]. Large amplitude
motions have also been observed for other ABC exporters in lipid envi-
ronments [45,46].
In the absence of nucleotides, MAS NMR spectra obtained for both
the 15N-tryptophan aswell as 15N-lysine labeled LmrA are characterized
by broad lines (Figs. 2, 3). This is indicative of various conformations
being sampled by the protein, an observation that would be in agree-
ment with EPR data indicating that LmrA is motionally dynamic in the
absence of nucleotides [10]. Exceptions to the broad MAS NMR reso-
nances are the sidechains of the lysine residues. They show a very nar-
row and distinct peak at a single chemical shift value. Since most
lysine residues in LmrA are found at the protein surface and the aminegroup caps a mobile butyl group, it could probably be expected that
the 15Nζ lysine sidechains gives rise to a single sharp peak.
Interestingly, nucleotide trapping changed this picture. It led to
sharpened andmore deﬁned peaks for the 15N amino acid selectively la-
beled LmrA samples. These changes were apparent in both the back-
bone as well as the sidechain resonances (Figs. 2, 3). Alterations in
peak shape and position are indicative of conformational and dynamic
changes within a protein. The large number of affected peaks, both in
the 15N-lysine as well as the 15N-tryptophan labeled samples, renders
it unlikely that it is solely a direct contribution of nucleotide interaction.
i.e. just affecting residues in direct contact with the nucleotide. It has
been shown previously with 2H ssNMR on LmrA that upon nucleotide
binding, the NBDs [as whole domains] of LmrA become rigid as opposed
to the extreme domain ﬂexibility of the NBDs in the absence of nucleo-
tide [26]. In addition, EPR studies on ABC exporters showed that nucle-
otide binding decreases their overall conformational space [10,40,47].
Particularly intriguing is the observation that LmrA trapping leads to
the appearance of a sidechain 15Nζ resonance that corresponds to 1/25th
of the total side chain 15Nζ resonance integral. Because NMR is a quanti-
tative technique, the integration of a peak should principally yield infor-
mation on how many residues contribute to it. This additional peak
would therefore be on the order of a single lysine sidechain out of the
29 (plus one from the tag) per monomer in total. However, a perfect es-
timate howmany lysine 15Nζ resonances contribute to this peak is difﬁ-
cult, because depending on their respective rigidity, the CP efﬁciency for
chemically identical residues can be different, so any interpretation
should be made with extreme care. Nonetheless, in light of the close
proximity (b4 Å) of lysine K388 of the Walker A motif to the nucleotide
γ-phosphate (as demonstrated for example in a Sav1866 crystal struc-
ture [35]) it is tempting to speculate that this resonance corresponds to
the sidechain of K388. Nucleotide binding should change the local chem-
ical environment of residue K388 and therefore inﬂuence its chemical
shift. This effect would be enhanced further under the experimental con-
ditions, because trapping was carried out with BeFx, which replaces the
γ-phosphate of ATP and places a strongly electronegative moiety in
close proximity of K388.
To investigate whether nucleotide binding really has a strong effect
on the dynamics of residue K388, we turned to solution NMR on the
15N-lysine labeled isolated NBD. Out of the nine lysine residues within
LmrA–NBD, the resonance of K388 is the only one that is missing from
the spectrum in the absence of nucleotides indicating that it is in inter-
mediate conformational exchange. Encouragingly, nucleotide binding
led to the appearance of a sharp lysine 388 resonance thus highlighting
that K388's motion signiﬁcantly changes upon nucleotide binding. Be-
cause it is now in a single deﬁned conformation, this suggests that the
nucleotide has a rigidifying effect on the structure of theNBDand in par-
ticular the nucleotide binding site. This ﬁnding also shows that K388 is
indeed very strongly affected by the presence of a nucleotide and thus
lends some credence to our tentative MAS NMR assignment of K388.
If our tentative MAS NMR peak assignment is correct, it implies that
one Walker A lysine residue per LmrA monomer is affected by nucleo-
tide binding, not one per homodimer. It has been discussed previously
whether ATP hydrolysis is simultaneous, random or sequential in the
two NBDs and whether both sides can be trapped with transition state
analogs at the same time [48,49]. At least under our experimental con-
ditions, it seems that both ATP siteswithin a homodimer can be trapped.
However, we cannot make conclusions as to the order of this process:
whether e.g. one site hydrolyses the nucleotide ﬁrst and becomes
trapped before the second site begins hydrolysis or whether both sites
act independently and/or simultaneously.
Out of the two tryptophan residues in the NBD, only W421 “senses”
the presence of the nucleotide (Fig. 5, S4). This residue is located N-
terminal to the “Q-loop”, a sensor for the ATP loading status of the
NBD and presumably one of the communication channels between
NBD and TMD [50]. At the same time, W421 is in close proximity to
the helix belonging to the Walker A motif at whose end residue K388
3164 U.A. Hellmich et al. / Biochimica et Biophysica Acta 1848 (2015) 3158–3165sits (Fig. 5). This indicates that local changes (such as binding of a nucle-
otide) can be propagated throughout the entire domain, a certain re-
quirement for efﬁcient coupling of ATP hydrolysis and substrate
transport.
The observed changes in the 15N backbone frequencies of the 15N-
TROSY-HSQC-spectra correspond well to the spectral differences ob-
served for the solid-state 1D-15N-spectra with regard to the location of
the observed shift changes. However, especially in the upﬁeld region of
the solid-state 15N-lysine spectrum (chemical shift values b115 ppm)
for full-length LmrA corresponding mainly to α-helical shifts, the ob-
served changes are more extensive than can be explained with changes
in the NBD alone. Our data thus indicate that nucleotide binding triggers
conformational and dynamical changes beyond the NBD, reaching far
into the TMDs and that it affects transporter dynamics on a global as
well as a local level.
5. Conclusions
We show by solid-state NMR on full-length LmrA that nucleotide
binding causes changes in line width and peak position of selectively la-
beled residues. In particular, the conserved lysine in theWalker-Amotif
could be tentatively assigned. These observations are supported by solu-
tion state NMR on isolated NBDs, which also show a speciﬁc response of
K388 upon nucleotide binding. Our data show that NMR spectroscopy
offers valuable information about ABC transporters, which are highly
complementary to X-ray and EPR spectroscopy approaches.
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